Gamifant (Emapalumab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gamifant (Emapalumab), covering 2025-04-30 to 2025-04-30. Get the full timeline:
Most recent: Clinical Trial Update: Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis [Phase 2, Phase 3]